Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

Core Insights - Intelligent Bio Solutions Inc. (INBS) has secured a significant contract with a major public transport operator in London, covering 14 operational sites and employing over 4,400 staff [1] - The deployment of INBS's Intelligent Fingerprinting Drug Screening System will take place across a bus network that serves over one million passengers daily, utilizing more than 1,400 low-emission vehicles [2] - The CEO of INBS highlighted the advantages of their technology, including rapid drug testing, reduced financial loss from wait times, and improved workforce efficiency [3] Company Overview - INBS specializes in intelligent, rapid, non-invasive testing solutions, with a focus on drug screening through fingerprint sweat analysis [5] - The company's drug testing technology is currently used by over 450 accounts in 24 countries, with plans for expansion in Europe, the Middle East, Africa, Asia Pacific, and the U.S. [4] - INBS aims to secure regulatory clearance from the U.S. FDA to enter the U.S. market in 2025 [4]